Physician profile
Michelle Buchanan
NPI 1700378668
$1,665.23
in general payments reported to CMS, 2019-2025
17 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $824 · 2022: $453 · 2023: $101 · 2024: $88.27 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $260.87 | 2021-2025 | Freestyle Libre 3 |
| Abbvie INC. | $233.87 | 2021-2025 | |
| Novo Nordisk INC | $190.19 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.48 | 2021-2022 | |
| Allergan, INC. | $172.13 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $165.32 | 2021-2022 | |
| Mentor Worldwide LLC | $122.51 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Janssen Pharmaceuticals, INC | $99.13 | 2021 | |
| Lilly USA, LLC | $53.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $32.48 | 2025 | |
| Glaxosmithkline, LLC. | $31.08 | 2021 | |
| Esperion Therapeutics, INC. | $29.39 | 2021 | |
| Pfizer INC. | $26.43 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $18.76 | 2022 | |
| Amgen INC. | $15.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $13.27 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.